HomeSearchGlobal LocationsContact UsGenzyme Websites
About GenzymeOur ResearchOur ProductsOur Commitment
Genzyme

Corporate Info
Investors
News
Investor Events
Financial Reports
Guidance and Reconciliation
Research Pipeline
Analyst Coverage
Corporate Governance
Frequently Asked Questions
News
Partnering
Genzyme Events
Careers
Global Locations

Analyst Coverage

Argus Research

Martha Freitag

Bank of America Merrill Lynch

Rachel McMinn

Barclays Capital

Jim Birchenough

Bernstein Research

Geoffrey Porges

BDR Research Group

Matt Duffy & Matt Jacobson

Collins Stewart

Salveen Kochnover

Cowen & Company

Phil Nadeau

Credit Suisse

Michael Aberman

Deutsche Bank

Mark Schoenebaum

FTN Equity Capital Markets

Biren Amin

Goldman Sachs

Davis Bu

Jefferies & Co.

Eun Yang

JP Morgan Chase

Geoffrey Meacham

Lazard Capital Markets

Bill Tanner

Leerink Swann

Joshua Schimmer

Morgan Joseph & Co.

Shiv Kapoor

Morgan Stanley

Steven Harr

Oppenheimer & Co.

Brian Abrahams

RBC Capital Markets

Michael Yee

Robert W. Baird

Chris J. Raymond

Smith Barney Citigroup

Yaron Werber

Standard & Poor’s

Frank DiLorenzo

Summer Street Research Partners

Jon Stephenson

Thomas Weisel Partners

Stephen Willey

UBS Research

Maged Shenouda

Wells Fargo

Aaron Reames

William Blair

John Sonnier

The analysts listed follow Genzyme Corporation. We are providing this list as a service and not as an endorsement or adoption of the information provided by these analysts. Any opinions or estimates regarding the performance of Genzyme made by these analysts are theirs and do not represent the opinions of Genzyme. We are not responsible for information provided in analyst reports, including inaccuracies they may contain. Some of the analysts firms may be market-makers in Genzyme's stock and/or hold other long or short positions in the stock, and may provide services to Genzyme for which they are compensated.



CONTACT INFORMATION:
Genzyme Investor Relations
500 Kendall Street
Cambridge, MA 02142
T: 617 252 7500


Patrick Flanigan – 617 768 6563


Investor Information Line

U.S. T: 800 905 4369
Outside the U.S. T: 678 999 4572

Shareholder Contact

For questions about your shares, replacement of a lost stock certificate or a change of address call our transfer agent.

American Stock Transfer

59 Maiden Lane
New York, NY 10038
T: 212 936 5100
or
Genzyme Shareholder Services
T: 617 768 6686

Terms and Conditions of Use | Privacy Policy | © 2002-2009 Genzyme Corporation. All rights reserved.